• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Scancell Holdings PLC (SCLP)

ORD 1P
Sell: 90.00p|Buy: 92.00p|Change: 0.80 (0.89%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Company profile

Scancell Holdings PLC is a clinical-stage biotechnology company developing treatments for unmet needs in cancer. The Company leverages its ImmunoBody and Moditope platforms to develop targeted, off-the-shelf, patient-accessible active immunotherapies designed to generate safe, potent, and long-lasting tumour-specific immunity. Its product, iSCIB1+, is an ImmunoBody DNA active immunotherapy that has demonstrated monotherapy activity in adjuvant melanoma. The ImmunoBody platform uses DNA-encoded modified antibodies engineered to express epitopes from cancer antigens and target activated antigen-presenting cells in vivo. iSCIB1+ is developed for the treatment of melanoma with checkpoint inhibitors and is administered by needle-free intramuscular injection.

Address

Robert Robinson Avenue
John Eccles House, Oxford Science Park
Oxford
GBR
OX4 4GP

Telephone

+44 1865338069

Website

https://www.scancell.co.uk

Sector 

Healthcare

Forecast key dates

NameKey Date
Scancell Holdings PLC Annual Report for 20272027-10-15T00:00:00
Scancell Holdings PLC Fourth Quarter Earnings Results for 20272027-10-08T00:00:00
Scancell Holdings PLC Second Quarter Earnings Conference Call for 20272027-01-29T14:00:00
Scancell Holdings PLC Second Quarter Earnings Results for 20272027-01-29T00:00:00
Scancell Holdings PLC Annual General Meeting for 20262026-10-30T15:00:00
Scancell Holdings PLC Annual Report for 20262026-10-15T00:00:00
Scancell Holdings PLC Fourth Quarter Earnings Results for 20262026-10-09T00:00:00

Previous key dates

NameKey Date
Scancell Holdings PLC Annual General Meeting for 20262026-10-30T15:00:00
Scancell Holdings PLC Annual Report for 20262026-10-15T00:00:00
Scancell Holdings PLC Fourth Quarter Earnings Results for 20262026-10-09T00:00:00
H.C. Wainwright 28(th) Annual Global Investment Conference2026-09-16T11:30:00
Scancell Holdings PLC Second Quarter Earnings Conference Call for 20262026-01-29T14:00:00
Scancell Holdings PLC Second Quarter Earnings Result for 20262026-01-29T00:00:00
Scancell Holdings PLC Annual General Meeting for 20252025-10-30T15:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.